{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:59:00Z","timestamp":1794268740188,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>MCC950 a potent, highly specific small molecule inhibitor of canonical and noncanonical activation of NLRP3 inflammasome has been evaluated in a multitude of NLRP3 driven inflammatory diseases. However, the effect of MCC950 on colonic inflammation has not yet been reported. In the present study we investigated the effect of MCC950 in a spontaneous chronic colitis mouse model Winnie, which mimics human ulcerative colitis. Oral administration of 40\u2009mg\/kg MCC950 commencing at Winnie week seven for three weeks significantly improved body weight gain, colon length, colon weight to body weight ratio, disease activity index and histopathological scores. MCC950 significantly suppressed release of proinflammatory cytokines IL-1\u03b2, IL-18, IL1-\u03b1, IFN\u03b3, TNF-\u03b1, IL6, IL17, chemokine MIP1a and Nitric Oxide in colonic explants. Moreover, MCC950 resulted in a significant decrease of IL-1\u03b2 release and activation of caspase-1 in colonic explants and macrophage cells isolated from Winnie. Complete inhibition with MCC950 in Winnie colonic explants shows, for the first time, the contribution of inflammatory effects resulting exclusively from canonical and noncanonical NLRP3 inflammasome activation in colitis. Taken together, our results illustrate the efficacy of MCC950 in the treatment of murine ulcerative colitis and provides avenue for a potential novel therapeutic agent for human inflammatory bowel diseases.<\/jats:p>","DOI":"10.1038\/s41598-018-26775-w","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T07:23:25Z","timestamp":1527665005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":298,"title":["MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-9940","authenticated-orcid":false,"given":"Agampodi Promoda","family":"Perera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchira","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Gundamaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Southam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhwinder Singh","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avril A. B.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Schroder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Kunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1688-8043","authenticated-orcid":false,"given":"Rajaraman","family":"Eri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"key":"26775_CR1","first-page":"237","volume":"5","author":"A Ponder","year":"2013","unstructured":"Ponder, A. & Long, M. D. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 5, 237\u2013247 (2013).","journal-title":"Clin Epidemiol."},{"key":"26775_CR2","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","volume":"138","author":"J Terzi\u0107","year":"2010","unstructured":"Terzi\u0107, J., Grivennikov, S., Karin, E. & Karin, M. Inflammation and Colon Cancer. Gastroenterology. 138, 2101\u20132114.e2105 (2010).","journal-title":"Gastroenterology."},{"key":"26775_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-62703-523-1_14","volume":"1040","author":"E Elinav","year":"2013","unstructured":"Elinav, E., Thaiss, C. A. & Flavell, R. A. Analysis of microbiota alterations in inflammasome-deficient mice. Methods Mol Biol. 1040, 185\u2013194 (2013).","journal-title":"Methods Mol Biol."},{"key":"26775_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K. & Tschopp, J. The inflammasomes. Cell. 140, 821\u2013832 (2010).","journal-title":"Cell."},{"key":"26775_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon, F., Mayor, A. & Tschopp, J. The Inflammasomes: Guardians of the Body. Annual Review of Immunology. 27, 229\u2013265 (2009).","journal-title":"Annual Review of Immunology."},{"key":"26775_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 464, 1357\u20131361 (2010).","journal-title":"Nature."},{"key":"26775_CR7","doi-asserted-by":"publisher","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","volume":"5","author":"K Rajamaki","year":"2010","unstructured":"Rajamaki, K. et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One. 5, e11765 (2010).","journal-title":"PLoS One."},{"key":"26775_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., Burns, K. & Tschopp, J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular Cell. 10, 417\u2013426 (2002).","journal-title":"Molecular Cell."},{"key":"26775_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature. 479, 117\u2013121 (2011).","journal-title":"Nature."},{"key":"26775_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2249.1995.tb03793.x","volume":"102","author":"G Bioque","year":"1995","unstructured":"Bioque, G. et al. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol. 102, 379\u2013383 (1995).","journal-title":"Clin Exp Immunol."},{"key":"26775_CR11","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.4049\/jimmunol.154.5.2434","volume":"154","author":"V Casini-Raggi","year":"1995","unstructured":"Casini-Raggi, V. et al. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol. 154, 2434\u20132440 (1995).","journal-title":"J Immunol."},{"key":"26775_CR12","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1084\/jem.20111453","volume":"209","author":"M Coccia","year":"2012","unstructured":"Coccia, M. et al. IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med. 209, 1595\u20131609 (2012).","journal-title":"J Exp Med."},{"key":"26775_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/gut.42.2.214","volume":"42","author":"ME McAlindon","year":"1998","unstructured":"McAlindon, M. E., Hawkey, C. J. & Mahida, Y. R. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut. 42, 214\u2013219 (1998).","journal-title":"Gut."},{"key":"26775_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/gut.31.6.686","volume":"31","author":"M Ligumsky","year":"1990","unstructured":"Ligumsky, M., Simon, P. L., Karmeli, F. & Rachmilewitz, D. Role of interleukin 1 in inflammatory bowel disease\u2013enhanced production during active disease. Gut. 31, 686\u2013689 (1990).","journal-title":"Gut."},{"key":"26775_CR15","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2174\/13894501113149990006","volume":"14","author":"T Kanai","year":"2013","unstructured":"Kanai, T., Kamada, N. & Hisamatsu, T. Clinical strategies for the blockade of IL-18 in inflammatory bowel diseases. Curr Drug Targets. 14, 1392\u20131399 (2013).","journal-title":"Curr Drug Targets."},{"key":"26775_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.it.2011.01.003","volume":"32","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk, F. L., Netea, M. G., Dinarello, C. A. & Joosten, L. A. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol. 32, 110\u2013116 (2011).","journal-title":"Trends Immunol."},{"key":"26775_CR17","doi-asserted-by":"publisher","first-page":"R1264","DOI":"10.1152\/ajpregu.2001.281.4.R1264","volume":"281","author":"B Siegmund","year":"2001","unstructured":"Siegmund, B. et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol. 281, R1264\u20131273 (2001).","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"26775_CR18","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gut.50.6.812","volume":"50","author":"PV Sivakumar","year":"2002","unstructured":"Sivakumar, P. V. et al. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut. 50, 812\u2013820 (2002).","journal-title":"Gut."},{"key":"26775_CR19","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s10620-007-9802-8","volume":"52","author":"C Bauer","year":"2007","unstructured":"Bauer, C. et al. The ICE Inhibitor Pralnacasan Prevents DSS-Induced Colitis in C57BL\/6 Mice and Suppresses IP-10 mRNA but Not TNF-\u03b1 mRNA Expression. Digestive Diseases and Sciences. 52, 1642\u20131652 (2007).","journal-title":"Digestive Diseases and Sciences."},{"key":"26775_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1124\/jpet.103.057059","volume":"308","author":"F Loher","year":"2004","unstructured":"Loher, F. et al. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. J Pharmacol Exp Ther. 308, 583\u2013590 (2004).","journal-title":"J Pharmacol Exp Ther."},{"key":"26775_CR21","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gut.2009.197822","volume":"59","author":"C Bauer","year":"2010","unstructured":"Bauer, C. et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 59, 1192\u20131199 (2010).","journal-title":"Gut."},{"key":"26775_CR22","doi-asserted-by":"crossref","unstructured":"Perera, A. P., Kunde, D. & Eri, R. NLRP3 Inhibitors as potential therapeutic agents for treatment of Inflammatory Bowel Disease. Curr Pharm Des. (2017).","DOI":"10.2174\/1381612823666170201162414"},{"key":"26775_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 21, 248\u2013255 (2015).","journal-title":"Nat Med."},{"key":"26775_CR24","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.4049\/jimmunol.1600035","volume":"197","author":"MJ Primiano","year":"2016","unstructured":"Primiano, M. J. et al. Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation. J Immunol. 197, 2421\u20132433 (2016).","journal-title":"J Immunol."},{"key":"26775_CR25","doi-asserted-by":"publisher","first-page":"16567","DOI":"10.1074\/jbc.M211596200","volume":"278","author":"RE Laliberte","year":"2003","unstructured":"Laliberte, R. E. et al. Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing. J Biol Chem. 278, 16567\u201316578 (2003).","journal-title":"J Biol Chem."},{"key":"26775_CR26","doi-asserted-by":"crossref","unstructured":"He, Y., Zeng, M. Y., Yang, D. H., Metro, B. & Nunez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 530, 354-+ (2016).","DOI":"10.1038\/nature16959"},{"key":"26775_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.3333","volume":"17","author":"HX Shi","year":"2016","unstructured":"Shi, H. X. et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nature Immunology. 17, 250\u2013258 (2016).","journal-title":"Nature Immunology."},{"key":"26775_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ni.3391","volume":"17","author":"F Van Hauwermeiren","year":"2016","unstructured":"Van Hauwermeiren, F. & Lamkanfi, M. The NEK-sus of the NLRP3 inflammasome. Nature Immunology. 17, 223\u2013224 (2016).","journal-title":"Nature Immunology."},{"key":"26775_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.kint.2016.03.035","volume":"90","author":"I Ludwig-Portugall","year":"2016","unstructured":"Ludwig-Portugall, I. et al. An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. Kidney International. 90, 525\u2013539 (2016).","journal-title":"Kidney International."},{"key":"26775_CR30","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/bph.13230","volume":"173","author":"SM Krishnan","year":"2016","unstructured":"Krishnan, S. M. et al. Inflammasome activity is essential for one kidney\/deoxycorticosterone acetate\/salt-induced hypertension in mice. British Journal of Pharmacology. 173, 752\u2013765 (2016).","journal-title":"British Journal of Pharmacology."},{"key":"26775_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10753-016-0449-5","volume":"40","author":"A Nalbandian","year":"2017","unstructured":"Nalbandian, A. et al. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy. Inflammation. 40, 21\u201341 (2017).","journal-title":"Inflammation."},{"key":"26775_CR32","doi-asserted-by":"crossref","unstructured":"Pinar, A. et al. PB1-F2 Peptide Derived from Avian Influenza A Virus H7N9 Induces Inflammation via Activation of the NLRP3 Inflammasome. Journal of Biological Chemistry. 292, 826-+ (2017).","DOI":"10.1074\/jbc.M116.756379"},{"key":"26775_CR33","doi-asserted-by":"crossref","unstructured":"Tate, M. D. et al. Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition. Scientific Reports. 6 (2016).","DOI":"10.1038\/srep27912"},{"key":"26775_CR34","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.18632\/aging.101255","volume":"9","author":"QN Dinh","year":"2017","unstructured":"Dinh, Q. N. et al. Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress. Aging-Us. 9, 1595\u20131606 (2017).","journal-title":"Aging-Us."},{"key":"26775_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.burns.2016.09.001","volume":"43","author":"JR Deuis","year":"2017","unstructured":"Deuis, J. R., Yin, K., Cooper, M. A., Schroder, K. & Vetter, I. Role of the NLRP3 inflammasome in a model of acute burn-induced pain. Burns. 43, 304\u2013309 (2017).","journal-title":"Burns."},{"key":"26775_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fimmu.2017.00036","volume":"8","author":"C Pellegrini","year":"2017","unstructured":"Pellegrini, C., Antonioli, L., Lopez-Castejon, G., Blandizzi, C. & Fornai, M. Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation. Front Immunol. 8, 36 (2017).","journal-title":"Front Immunol."},{"key":"26775_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jss.2006.07.050","volume":"140","author":"LS Poritz","year":"2007","unstructured":"Poritz, L. S. et al. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res. 140, 12\u201319 (2007).","journal-title":"J Surg Res."},{"key":"26775_CR38","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/gut.39.2.234","volume":"39","author":"J Ni","year":"1996","unstructured":"Ni, J., Chen, S. F. & Hollander, D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut. 39, 234\u2013241 (1996).","journal-title":"Gut."},{"key":"26775_CR39","doi-asserted-by":"crossref","unstructured":"Chassaing, B., Aitken, J. D., Malleshappa, M. & Vijay-Kumar, M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 104, Unit 15.25 (2014).","DOI":"10.1002\/0471142735.im1525s104"},{"key":"26775_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/mi.2010.74","volume":"4","author":"RD Eri","year":"2011","unstructured":"Eri, R. D. et al. An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity. Mucosal Immunol. 4, 354\u2013364 (2011).","journal-title":"Mucosal Immunol."},{"key":"26775_CR41","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1042\/BST0391081","volume":"39","author":"MA McGuckin","year":"2011","unstructured":"McGuckin, M. A., Eri, R. D., Das, I., Lourie, R. & Florin, T. H. Intestinal secretory cell ER stress and inflammation. Biochem Soc Trans. 39, 1081\u20131085 (2011).","journal-title":"Biochem Soc Trans."},{"key":"26775_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/gut.35.3.353","volume":"35","author":"RD Pullan","year":"1994","unstructured":"Pullan, R. D. et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut. 35, 353\u2013359 (1994).","journal-title":"Gut."},{"key":"26775_CR43","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1371\/journal.pmed.0050054","volume":"5","author":"CK Heazlewood","year":"2008","unstructured":"Heazlewood, C. K. et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 5, e54 (2008).","journal-title":"PLoS Med."},{"key":"26775_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00441-015-2251-3","volume":"362","author":"AA Rahman","year":"2015","unstructured":"Rahman, A. A., Robinson, A. M., Jovanovska, V., Eri, R. & Nurgali, K. Alterations in the distal colon innervation in Winnie mouse model of spontaneous chronic colitis. Cell and Tissue Research. 362, 497\u2013512 (2015).","journal-title":"Cell and Tissue Research."},{"key":"26775_CR45","doi-asserted-by":"publisher","first-page":"G85","DOI":"10.1152\/ajpgi.00210.2016","volume":"312","author":"AM Robinson","year":"2017","unstructured":"Robinson, A. M. et al. Alterations of colonic function in the Winnie mouse model of spontaneous chronic colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 312, G85\u2013G102 (2017).","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology."},{"key":"26775_CR46","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1097\/MIB.0000000000000970","volume":"22","author":"AM Robinson","year":"2016","unstructured":"Robinson, A. M. et al. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 22, 2767\u20132787 (2016).","journal-title":"Inflammatory Bowel Diseases."},{"key":"26775_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/ng.285","volume":"41","author":"AC Villani","year":"2009","unstructured":"Villani, A. C. et al. Common variants in the NLRP3 region contribute to Crohn\u2019s disease susceptibility. Nat Genet. 41, 71\u201376 (2009).","journal-title":"Nat Genet."},{"key":"26775_CR48","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1084\/jem.20100050","volume":"207","author":"IC Allen","year":"2010","unstructured":"Allen, I. C. et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med. 207, 1045\u20131056 (2010).","journal-title":"J Exp Med."},{"key":"26775_CR49","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.bcp.2013.03.008","volume":"85","author":"W Liu","year":"2013","unstructured":"Liu, W. et al. A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome. Biochem Pharmacol. 85, 1504\u20131512 (2013).","journal-title":"Biochem Pharmacol."},{"key":"26775_CR50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF01993274","volume":"34","author":"TK Thomas","year":"1991","unstructured":"Thomas, T. K. et al. Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model. Agents and Actions. 34, 187\u2013190 (1991).","journal-title":"Agents and Actions."},{"key":"26775_CR51","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/gast.2001.29579","volume":"121","author":"T Ten Hove","year":"2001","unstructured":"Ten Hove, T. et al. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterology. 121, 1372\u20131379 (2001).","journal-title":"Gastroenterology."},{"key":"26775_CR52","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/mi.2014.1","volume":"7","author":"J Zhang","year":"2014","unstructured":"Zhang, J., Fu, S., Sun, S., Li, Z. & Guo, B. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunology. 7, 1139\u20131150 (2014).","journal-title":"Mucosal Immunology."},{"key":"26775_CR53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1369\/jhc.6A7101.2006","volume":"55","author":"JA Kummer","year":"2007","unstructured":"Kummer, J. A. et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem. 55, 443\u2013452 (2007).","journal-title":"J Histochem Cytochem."},{"key":"26775_CR54","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1006\/cyto.1998.0355","volume":"10","author":"Y Arai","year":"1998","unstructured":"Arai, Y., Takanashi, H., Kitagawa, H. & Okayasu, I. Involvement of Interleukin-1 in the development of ulcerative colitis induced by DextranSulfate Sodium in mice. Cytokine. 10, 890\u2013896 (1998).","journal-title":"Cytokine."},{"key":"26775_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01917-2","volume":"8","author":"X Yao","year":"2017","unstructured":"Yao, X. et al. Remodelling of the gut microbiota by hyperactive NLRP3 induces regulatory T cells to maintain homeostasis. Nature Communications. 8, 1896 (2017).","journal-title":"Nature Communications."},{"key":"26775_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","volume":"187","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome. Journal of Cell Biology. 187, 61\u201370 (2009).","journal-title":"Journal of Cell Biology."},{"key":"26775_CR57","doi-asserted-by":"crossref","unstructured":"Liu, L. et al. The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans. J Crohns Colitis. (2016).","DOI":"10.1093\/ecco-jcc\/jjw219"},{"key":"26775_CR58","doi-asserted-by":"publisher","first-page":"972","DOI":"10.4161\/auto.28374","volume":"10","author":"W Guo","year":"2014","unstructured":"Guo, W. et al. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer. Autophagy. 10, 972\u2013985 (2014).","journal-title":"Autophagy."},{"key":"26775_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep28370","volume":"6","author":"X He","year":"2016","unstructured":"He, X. et al. Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis. Sci Rep. 6, 28370 (2016).","journal-title":"Sci Rep."},{"key":"26775_CR60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jnutbio.2015.12.002","volume":"30","author":"YK Marquez-Flores","year":"2016","unstructured":"Marquez-Flores, Y. K., Villegas, I., Cardeno, A., Rosillo, M. A. & Alarcon-de-la-Lastra, C. Apigenin supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathways. J Nutr Biochem. 30, 143\u2013152 (2016).","journal-title":"J Nutr Biochem."},{"key":"26775_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.advms.2016.09.001","volume":"62","author":"Z Kmiec","year":"2017","unstructured":"Kmiec, Z., Cyman, M. & Slebioda, T. J. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Adv Med Sci. 62, 1\u201316 (2017).","journal-title":"Adv Med Sci."},{"key":"26775_CR62","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.clnu.2010.03.003","volume":"29","author":"S S\u00e1nchez-Fidalgo","year":"2010","unstructured":"S\u00e1nchez-Fidalgo, S. et al. Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice. Clinical Nutrition. 29, 663\u2013673 (2010).","journal-title":"Clinical Nutrition."},{"key":"26775_CR63","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1084\/jem.20160462","volume":"214","author":"V Neudecker","year":"2017","unstructured":"Neudecker, V. et al. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 214, 1737\u20131752 (2017).","journal-title":"J Exp Med."},{"key":"26775_CR64","doi-asserted-by":"crossref","unstructured":"Lean, Q. Y. et al. Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses. Plos One. 10 (2015).","DOI":"10.1371\/journal.pone.0134259"},{"key":"26775_CR65","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/carcin\/21.4.757","volume":"21","author":"HS Cooper","year":"2000","unstructured":"Cooper, H. S., Murthy, S., Kido, K., Yoshitake, H. & Flanigan, A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis. 21, 757\u2013768 (2000).","journal-title":"Carcinogenesis."},{"key":"26775_CR66","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.3748\/wjg.v22.i37.8334","volume":"22","author":"S Randall-Demllo","year":"2016","unstructured":"Randall-Demllo, S. et al. Characterisation of colonic dysplasia-like epithelial atypia in murine colitis. World Journal of Gastroenterology. 22, 8334\u20138348 (2016).","journal-title":"World Journal of Gastroenterology."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26775-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26775-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26775-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T18:06:05Z","timestamp":1693677965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26775-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26775"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26775-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8618"}}